AZOPT Eye drops, suspension (2018)
Active ingredients: Brinzolamide
Product Name and Form
AZOPT 10 mg/ml eye drops, suspension.
Eye drops, suspension.
White to off-white suspension.
Qualitative and Quantitative Composition
Each ml of suspension contains 10 mg brinzolamide.
Excipient with known effect: Each ml of suspension contains 0.1 mg benzalkonium chloride.
For a full list of excipients, see section 6.1.
Brinzolamide is an inhibitor of carbonic anhydrase II (CA-II). Carbonic anhydrase (CA) is an enzyme found in many tissues of the body, including the eye. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humour secretion resulting in a reduction in intraocular pressure (IOP) which is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss.
Hydrochloric acid/sodium hydroxide (to adjust pH)
Pack sizes and Marketing
5 and 10 ml opaque low density polyethylene bottles with polypropylene screw caps (droptainer).
The following pack sizes are available: outer cartons containing 1 × 5 ml, 3 × 5 ml and 1 × 10 ml bottles. Not all pack sizes may be marketed.
Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
Date of first authorisation: 9 March 2000
Date of latest renewal: 29 January 2010